Barkby Group PLC (The) Verso Biosense signs agreement with hospital
March 25 2021 - 02:00AM
RNS Non-Regulatory
TIDMBARK
Barkby Group PLC (The)
25 March 2021
25 March 2021
The Barkby Group PLC
("Barkby", the "Group" or the "Company")
Verso Biosense signs agreement with Homerton University
Hospital
The Barbky Group PLC is pleased to announce that Verso Biosense,
an innovator in UK femtech focused on improving women's health, has
announced the signing of a product collaboration agreement with
Homerton University Hospital. Under the agreement, Homerton will
utilise Verso's uterine monitoring platform and will collaborate
with Verso to help refine the technology and biosensing platform to
meet the needs of fertility patients. Verso's platform captures
critical in-vivo, biosensing data for optimisation and
personalisation of IVF treatment, providing actionable insights for
clinicians and patients.
Homerton University Hospital is one of the leading IVF and
fertility centres in the UK and is recognised as an innovator in
embracing methods and systems that provide better and safer patient
care. This includes reviewing and collaborating on novel
technologies for the treatment of IVF and fertility.
Charles Dickson, Executive Chairman of Barkby, said:
"I am very excited by this next chapter for Verso Biosense as it
partners with some of the UK's leading IVF and fertility centers to
refine its technology and biosensing platform with the aim of
optimising fertility treatments for millions of women.
"The opportunity in women's health is significant and Verso
Biosense's technology has the potential to change diagnostic
paradigms across a wide range of further disciplines including
endometriosis, fibrosis, menopause and oncology."
Enquiries:
The Barkby Group PLC
Charles Dickson, Executive Chairman
Douglas Benzie, Chief Financial Officer
+44 (0) 20 7220
finnCap Ltd (Nomad and Broker) 0500
Carl Holmes/Simon Hicks (corporate finance)
Tim Redfern/Richard Chambers (ECM)
+44 (0) 20 3757
Camarco (Financial PR) 4994
Jennifer Renwick/Jake Thomas
Notes to editors
The Barkby Group PLC is a diversified group of high growth, high
quality businesses run by an entrepreneurial and experienced
management team. The existing wholly owned businesses within Barkby
include; Commercial Property Development, Barkby Hospitality
(comprising Barkby Pubs and Workshop Coffee) and Centurian
Automotive Ltd.
In addition to these businesses, Barkby Life Sciences has
invested in Verso Biosense, a digital health company aiming to
transform Women's Health with precision medicine, and its
subsidiary Cambridge Sleep Sciences Ltd has launched, SleepHub(TM),
a device which improves and facilitates natural sleep.
Barkby's strategy is to accelerate and maximise opportunities
within its existing businesses as well as continue to source and
invest in cash generative, growth businesses with the ability to
disrupt.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUSSRRAOUOUUR
(END) Dow Jones Newswires
March 25, 2021 03:00 ET (07:00 GMT)
Barkby (LSE:BARK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Barkby (LSE:BARK)
Historical Stock Chart
From Mar 2023 to Mar 2024